A prospective, open, single-arm, single-center Phase II study of Cadonilimab combined with anti-angiogenesis targeted agents in patients with advanced solid tumors dominated by colorectal cancer who have failed standard therapy
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/86669
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Test Group:Cadonilimab combined with anti-angiogenesis targeted agents
Primary outcome(s): Overall response rate
Study Design: Single arm
创建时间：
2023-04-15
